In humans, CML is primarily caused by the t(9;22)(q34;q11) translocation, leading to the formation of the Philadelphia chromosome (Ph) and the expression of the BCR-ABL fusion oncogene, responsible for driving the leukemogenic signal21. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.